HiFiBiO Therapeutics, a multinational biotherapeutics start-up that mobilizes the human immune system to combat disease, announced on Wednesday the completion of a US$67 million series C round of financing led by Boston-born investment company IDG Capital. The company’s existing shareholders Sequoia Capital China, Legend Star Capital, a venture capital arm of Chinese investment firm Legend […]

IDG Capital Leads $67M Series C Round In Biotech Start-Up HiFiBiO Therapeutics comes originally from China Money Network. All Rights Reserved.